Clinical Guides
Pleural Effusion
A clinically focused adult guide to pleural effusion in India, integrating cause-first assessment, thoracic ultrasound, safe fluid sampling and drainage, tuberculosis and malignancy pathways, pleural-infection emergencies, referral decisions and important evidence limitations.
MedNext Academy | 13 min read
Pleural Effusion
A clinically focused adult guide to pleural effusion in India, integrating cause-first assessment, thoracic ultrasound, safe fluid sampling and drainage, tuberculosis and malignancy pathways, pleural-infection emergencies, referral decisions and important evidence limitations.
Summary
Pleural effusion is abnormal fluid between the visceral and parietal pleura. It is a physical and imaging finding, not a final diagnosis. Heart failure, cirrhosis and renal disease commonly produce transudative physiology; infection, tuberculosis, malignancy, pulmonary embolism and inflammatory disease commonly produce exudates. More than one mechanism can coexist. The central clinical task is to identify respiratory or haemodynamic danger, decide whether aspiration is necessary, obtain interpretable samples safely, and pursue the cause without allowing a convenient label to end investigation.
Begin with an ABC assessment, oxygen saturation and the tempo of breathlessness. Suspected tension physiology, sepsis, empyema or massive fluid causing severe compromise needs immediate senior care. In a stable patient, history, examination, chest imaging and thoracic ultrasound establish the pattern and a safe procedural window. Ultrasound must guide pleural-fluid aspiration except when a true emergency makes delay more dangerous. Unilateral or otherwise unexplained fluid generally requires diagnostic evaluation; bilateral fluid in a convincing systemic syndrome may first be treated and reassessed.
Pleural-fluid interpretation uses paired blood and fluid protein and lactate dehydrogenase, cell differential, pH when infection is possible, microbiology and cytology selected to the clinical question. Tuberculosis and malignancy remain crucial Indian differentials, but neither should be diagnosed from one biomarker alone. Therapeutic drainage can relieve symptoms, yet it is not a substitute for diagnosing and treating the driver. Procedures require consent, trained operators, monitoring, documentation and a plan for complications.
How Common Is It?
Pleural effusion is encountered across emergency medicine, general medicine, respiratory medicine, oncology, cardiology and critical care. Its frequency cannot be represented by one useful population percentage because studies count different entities: an incidental radiographic finding, a symptomatic hospital presentation, a procedure episode or an effusion caused by a specific disease. The case mix also changes markedly between community clinics, district hospitals, tuberculosis services, cancer centres and intensive-care units. A precise-looking global prevalence would therefore mislead more than inform.
In Indian practice, tuberculosis has a higher prior probability than in many high-income settings, while parapneumonic disease, heart failure, renal or hepatic disease and malignancy remain common. The relative contribution varies by age, immune status, local TB epidemiology and referral pattern. Older age, smoking exposure, a known cancer, recurrent same-sided fluid or pleural nodularity raises concern for malignancy; fever, pleuritic pain and pneumonia raise concern for pleural infection. These are probability shifts, not diagnostic rules.
Clinical burden depends on volume, rate of accumulation, lung and cardiac reserve, non-expandable lung and the underlying illness. A slowly enlarging effusion may be surprisingly well tolerated, whereas a smaller collection can cause major symptoms in someone with severe cardiopulmonary disease. Recurrent malignant effusion creates repeated hospital contact and procedural burden. Loculation complicates infection and drainage. Service planning should use local laboratory, ultrasound, cytology, thoracoscopy and TB-pathway capacity rather than importing a headline rate from a dissimilar health system.
Risk Factors
Risk assessment is organised by mechanisms rather than by a memorised undifferentiated list. Raised hydrostatic pressure suggests heart failure; reduced oncotic pressure accompanies cirrhosis, nephrotic syndrome and severe hypoalbuminaemia. Infection risk rises with pneumonia, aspiration, poor dentition, alcohol dependence, immunosuppression and delayed presentation. Tuberculous pleuritis is more plausible with TB contact, previous TB, HIV, undernutrition, diabetes, chronic kidney disease, immunosuppressive treatment or residence in a high-burden community, but it may occur without a declared risk.
Malignant effusion is associated with lung, breast, ovarian and other metastatic cancers, mesothelioma and lymphoma. Ask about tobacco, occupational asbestos, previous cancer, unexplained weight loss, persistent unilateral chest pain and recurrent fluid. Pulmonary embolism, pancreatitis, oesophageal rupture, rheumatoid disease, systemic lupus erythematosus, post-cardiac injury, trauma and recent thoracic or abdominal surgery are less frequent but clinically consequential causes. Medicines including amiodarone, methotrexate, nitrofurantoin and selected anticancer or immunologic agents can be relevant; causality needs specialist review rather than an automatic stop instruction.
Procedure risk is a separate assessment. Anticoagulants, antiplatelets, coagulopathy, thrombocytopenia, renal failure, agitation, inability to cooperate, mechanical ventilation, very small or loculated collections, adherent lung, distorted anatomy and operator inexperience alter planning. None replaces real-time imaging and an individualized risk-benefit judgment. Ultrasound identifies fluid depth, diaphragm, lung and nearby viscera but does not make an inadequately trained operator competent. Diagnostic delay is itself hazardous when pus, haemothorax or rapidly progressive malignancy is possible, so risk mitigation should facilitate timely expert care rather than simply cancel investigation.
Diagnosis
History
Define onset, progression, exertional limitation, orthopnoea, pleuritic pain, fever, cough, sputum, haemoptysis, weight loss, night sweats and appetite. Ask about TB exposure or treatment, pneumonia, cancer, heart, liver and kidney disease, venous thromboembolism, pancreatitis, trauma, operations and medicines. Record smoking, asbestos and occupational exposure. Unilateral calf swelling, sudden pleuritic symptoms or syncope raises embolic concern. Establish prior imaging and whether the fluid recurred after drainage.
Examination
Record respiratory rate, saturation, pulse, blood pressure, temperature, work of breathing and mental state before a focused chest examination. A sizeable effusion may cause reduced expansion, stony dull percussion, reduced fremitus and diminished breath sounds; bronchial breathing can occur just above it. Look for raised venous pressure, oedema, cardiac signs, ascites, lymphadenopathy, breast or chest-wall abnormality, chronic liver disease and thromboembolism. Septic shock, tracheal or mediastinal displacement with compromise, or rapidly worsening hypoxaemia overrides routine sequencing.
Investigations
Chest radiography detects and patterns fluid but neither identifies its cause nor reliably defines a safe needle site. Thoracic ultrasound confirms fluid, estimates accessibility, identifies septation or pleural abnormality and guides aspiration in the procedural position. CT with contrast may assess pleura, lung, nodes, mediastinum and alternative disease; order timing thoughtfully because prior complete drainage can remove useful context while undrained fluid can obscure pleura. For unexplained fluid, send paired serum and pleural protein and LDH, cell count and differential, Gram stain and culture, and cytology. If infection is suspected, obtain pH promptly in a blood-gas syringe without local-anaesthetic contamination and inoculate suitable culture bottles. TB testing can include mycobacterial culture and tissue sampling; ADA supports rather than proves the diagnosis.
Differential Diagnosis
First distinguish true pleural fluid from mimics. Elevated hemidiaphragm, subpulmonic fluid, pleural thickening, lower-lobe collapse, diaphragmatic hernia, abdominal ascites and a large intrathoracic mass may imitate an effusion on one projection. Ultrasound usually resolves fluid versus solid tissue and helps recognise complex septation, but CT or specialist imaging may be required when anatomy remains uncertain. A haemodynamically unstable patient with unilateral opacity also requires consideration of haemothorax.
Classify fluid using Light's criteria with paired serum values. An exudate satisfies at least one protein or LDH criterion; a transudate satisfies none. Diuretic-treated heart failure can be misclassified as exudative, so the clinical syndrome and selected serum-to-fluid gradients can prevent a false pivot to invasive malignancy work-up. Neutrophil predominance supports an acute inflammatory process; lymphocyte predominance occurs in TB, malignancy and chronic processes but is not specific. Low pH or glucose narrows possibilities toward complicated infection, malignancy, rheumatoid pleuritis or oesophageal rupture. Milky fluid prompts triglyceride and chylomicron assessment; bloody fluid needs haematocrit interpretation rather than visual judgement alone.
Among exudates, separate parapneumonic effusion or empyema, tuberculous pleuritis, malignant effusion, embolism, pancreatitis, connective-tissue disease and post-procedural causes. Negative cytology does not exclude cancer; negative pleural-fluid microbiology does not exclude TB. Recurrent unilateral fluid, pleural thickening or nodularity may require image-guided pleural biopsy or thoracoscopy. Avoid treating response to diuretics, antibiotics or anti-tuberculosis drugs as a retrospective diagnostic test when a tissue diagnosis is feasible and malignancy remains possible.
Management
Stabilise airway, breathing and circulation; give oxygen to an appropriate target when hypoxaemic and treat sepsis or shock without waiting for complete pleural classification. Management then has two linked tracks: control the underlying disease and decide whether fluid needs diagnostic or therapeutic intervention. A convincing bilateral heart-failure pattern may be treated with optimized heart-failure therapy and early reassessment. A new unilateral, markedly asymmetric, persistent or clinically atypical collection usually warrants respiratory evaluation and ultrasound-guided sampling.
For diagnostic thoracentesis, confirm patient, side, indication, consent, imaging and specimen plan; position the patient safely; scan immediately before puncture without moving them; use aseptic technique and enter above the rib. Send all required samples at the first attempt. Therapeutic aspiration should be slow, preferably through a catheter when more than a small diagnostic volume is removed. The BTS statement advises a usual maximum of 1.5 litres in one attempt and stopping earlier for chest tightness, pain, persistent cough or worsening breathlessness. This is a safety ceiling, not a target. Do not apply vacuum bottles or wall suction for routine therapeutic aspiration.
Frank pus, positive pleural culture or biochemical evidence of complicated parapneumonic effusion usually requires antibiotics plus intercostal drainage, with ultrasound or CT defining locules. Poor progress prompts drain assessment, further imaging, intrapleural therapy in selected cases and early thoracic-surgical discussion. Recurrent symptomatic malignant effusion may be managed with pleurodesis or an indwelling pleural catheter according to lung expansion, prognosis, preference and local support. Tuberculous effusion requires an NTEP-aligned diagnostic and treatment pathway, not isolated drainage or empirical steroids.
Prescribing Information
There is no medicine that treats pleural fluid independently of its cause. In heart failure, diuretics and disease-modifying therapy are adjusted against congestion, renal function, electrolytes and blood pressure. In pneumonia-associated infection, start antibiotics promptly when clinically indicated and choose them from the local guideline, community or hospital acquisition, aspiration risk, recent antimicrobial exposure and microbiology. Pleural infection usually needs anaerobic coverage, but a universal regimen is unsafe because resistance, allergy, renal function and formulary differ. Obtain cultures without delaying treatment in a septic patient and narrow therapy when results permit.
Selected patients with pleural infection and residual collection after drainage may receive combined intrapleural tissue plasminogen activator and DNase under a specialist protocol. BTS describes 10 mg tPA plus 5 mg DNase twice daily for three days as the trial-based regimen, while acknowledging lower-dose tPA may be considered. Bleeding risk, anticoagulation, consent, administration sequence, drain handling and response require senior verification. Single-agent tPA or DNase should not be substituted casually, and intrapleural therapy does not rescue a malpositioned or blocked drain.
Anti-tuberculosis treatment follows current NTEP policy after appropriate diagnostic assessment and drug-susceptibility planning. ADA alone must not trigger unsupervised multidrug treatment; pleural-fluid Xpert has limited sensitivity and a negative result cannot exclude pleural TB. INDEX-TB does not recommend routine corticosteroids for pleural TB. Malignant effusion therapy may include systemic anticancer treatment, analgesia, pleurodesis or catheter care directed by oncology and pleural teams. Document every intrapleural drug as a high-risk procedure medicine, including dose, diluent, route, side, dwell instructions and observation plan.
When to Refer
Arrange emergency transfer or same-site senior intervention for severe respiratory distress, haemodynamic instability, suspected haemothorax, empyema with sepsis, rapidly accumulating fluid, mediastinal shift with compromise or deterioration during or after aspiration. Supply oxygen and resuscitation within competence, monitor continuously and use an equipped transport pathway. A large radiographic effusion in a comfortable patient is not automatically an emergency, while a modest collection in a shocked or hypoxaemic patient may be. Physiology and cause determine urgency.
Refer promptly to respiratory medicine for a new unexplained unilateral effusion, recurrent fluid, loculation, pleural thickening or nodularity, failed initial sampling, non-diagnostic cytology with continuing cancer concern, suspected TB, chylothorax or non-expandable lung. Thoracic surgery should be involved early when pleural infection does not improve with appropriate antibiotics and drainage, when a bronchopleural or oesophageal communication is suspected, or when tissue and definitive control require operative expertise. Oncology and palliative-care collaboration supports recurrent malignant fluid and symptom decisions.
A useful referral includes symptom trajectory, observations and oxygen, comorbid reserve, imaging and ultrasound findings, side and estimated accessibility, every prior procedure and volume removed, appearance and all pleural and paired serum results, microbiology, cytology, TB tests, medicines affecting bleeding, allergy, renal function and the patient's goals. In resource-limited districts, contact the receiving centre before another low-yield aspiration. Preserve samples and images where feasible and do not delay transfer merely to complete tests unavailable locally.
Red Flags
Severe or rapidly increasing breathlessness, cyanosis, exhaustion, confusion, hypotension, tachycardia, rising oxygen requirement or marked mediastinal displacement demands immediate reassessment. Fluid alone rarely creates classic tension physiology, so consider haemothorax, tension hydrothorax, coexisting pneumothorax, pulmonary embolism, sepsis and cardiac tamponade. Fever with pleuritic pain, persistent sepsis, purulent fluid, loculations or a low pleural pH suggests complicated parapneumonic effusion or empyema; antibiotics without source control may fail.
Cancer warnings include unexplained weight loss, haemoptysis, persistent unilateral pain, pleural nodularity, recurrent same-sided effusion, lymphadenopathy or a known tumour. TB warnings include constitutional symptoms, contact, HIV or other immunosuppression, but their absence is not exclusionary. Do not let a high ADA erase the possibility of lymphoma, empyema or another cause. Conversely, a negative smear, culture or nucleic-acid test on pleural fluid does not independently rule out pleural TB because microbiological yield can be low.
Procedural danger signals include new pleuritic pain, persistent cough, worsening dyspnoea, syncope, hypoxaemia, haemoptysis, expanding subcutaneous emphysema or haemodynamic change. Stop drainage, assess immediately and obtain appropriate imaging. Never continue because a planned volume has not been reached. A drain that stops swinging or bubbling may reflect resolution, blockage, displacement or disconnection; do not flush, clamp, withdraw or replace it without competent assessment. Avoid clamping a bubbling drain. Suspected wrong-side marking, loss of the ultrasound window or patient movement requires a fresh safety check, not procedural momentum.
Indian Clinical Context
India's pleural differential demands parallel attention to tuberculosis, bacterial infection and malignancy. The 2024 ICS-NCCP guideline was developed specifically because empirical treatment and reliance on Western case mixes can delay accurate diagnosis. A lymphocytic exudate with raised ADA may support pleural TB in the correct epidemiological setting, but age, immune status, laboratory method and competing diagnoses change its meaning. Pleural-fluid mycobacterial tests have limited sensitivity. When feasible, tissue for histopathology, culture and molecular testing improves diagnostic confidence and drug-resistance assessment.
INDEX-TB advises pleural aspiration with biochemical testing, differential count, mycobacterial microscopy and culture, and cytology. Its 2016 recommendations must be read alongside current NTEP drug and diagnostic policies rather than treated as a frozen prescribing schedule. Empirical anti-tuberculosis treatment can mask malignancy and delays tissue diagnosis; repeated empirical antibiotics can similarly postpone drainage of empyema. HIV testing and integrated counselling should be offered according to national policy where TB is suspected.
Access to thoracic ultrasound, blood-gas pleural pH, cytology, histopathology, thoracoscopy and cardiothoracic surgery differs greatly. Where a facility cannot safely sample or drain, the correct intervention is stabilization and coordinated referral, not blind landmark aspiration. Public medical colleges, district hospitals, NTEP services, cancer centres and private providers may form one patient's pathway. Record what test was actually performed, its laboratory method and specimen handling. International guidance informs principles, but device choice, antimicrobial policy and ambulatory catheter pathways require locally verified staffing, supplies and follow-up.
NMC Competency Mapping
The 2024 NMC undergraduate curriculum explicitly places recognition of pleural effusion and pneumothorax within GM28.9: the learner performs a systematic respiratory examination, measures respiratory rate and distress, assesses effort tolerance and breath sounds, and identifies consolidation and pleural signs. GM28.10 develops an aetiology-prioritised differential, while GM28.14 links the bedside assessment to pulse oximetry, arterial blood gas and chest-radiograph interpretation. These competencies support recognition and reasoning; they do not confer independent procedural authority.
For pleural effusion, an Indian medical graduate should obtain a structured history, recognise reduced expansion, dull percussion and diminished breath sounds, interpret the radiographic pattern, and explain when ultrasound changes safety and diagnosis. The learner should distinguish transudative from exudative mechanisms, apply Light's criteria with paired serum samples, interpret pH in suspected infection, and build separate pathways for parapneumonic, tuberculous and malignant effusions. Clinical reasoning includes noticing discordance: an apparent transudate with pleural nodularity, or an apparent exudate after diuresis.
Skills teaching should use simulation and supervised patients to cover consent, side verification, asepsis, specimen labelling, ultrasound anatomy and complication recognition. Independent thoracentesis, drain placement, intrapleural drug administration and thoracoscopy require local credentialing and direct supervision until competence is documented. Assessment should test escalation as well as recall: the safe graduate recognises sepsis, haemothorax and post-procedure pneumothorax, sends a complete paired sample set, and knows when local capability is insufficient.
Key Exam Pearls for NEET PG
Pleural effusion classically causes reduced movement, stony dull percussion, decreased tactile fremitus and diminished breath sounds; bronchial breathing or egophony may occur near the upper fluid level. On an erect chest radiograph, costophrenic-angle blunting and a meniscus are typical, but supine fluid layers posteriorly. Ultrasound is more sensitive for small fluid volumes, identifies septations and is required to choose a safe aspiration site. Massive unilateral opacity with contralateral mediastinal displacement suggests a large effusion; ipsilateral pull suggests volume loss instead.
Light's criteria define an exudate when pleural-fluid to serum protein exceeds 0.5, pleural-fluid to serum LDH exceeds 0.6, or pleural LDH exceeds two-thirds of the laboratory upper reference limit for serum LDH. Meeting any one criterion is sufficient. Diuresed heart failure can create a pseudoexudate. Neutrophils suggest an acute process; lymphocytes suggest TB, malignancy or chronic disease but do not diagnose one. In suspected infection, frank pus or positive culture establishes pleural infection, and low pH supports drainage decisions when sampling is reliable.
A high ADA is an adjunct for tuberculous effusion, not proof. Pleural-fluid Xpert has insufficient sensitivity to exclude TB when negative. Cytology may miss malignant pleural disease; persistent suspicion requires tissue strategy. Therapeutic aspiration is slow, usually limited to 1.5 litres per sitting and stopped sooner if symptoms develop. Never perform routine pleural-fluid aspiration without thoracic ultrasound. Never clamp a bubbling pneumothorax drain. The exam-quality management answer always treats the cause, specifies when drainage is needed and includes referral for non-resolving infection or suspected malignancy.
Frequently Asked Questions
Does every newly detected pleural effusion require immediate aspiration?
No. Severe compromise, suspected empyema or haemothorax may require urgent intervention, while a typical bilateral heart-failure pattern can sometimes be treated and reassessed first. A new unilateral, asymmetric, persistent or otherwise unexplained effusion usually needs specialist evaluation and ultrasound-guided diagnostic sampling. The decision depends on physiology, cause probability, size, accessibility and whether the result will change management.
Can a raised pleural-fluid ADA confirm tuberculous pleural effusion in India?
Not by itself. ADA changes probability in the context of an exudate, cell pattern, age, immune status and local TB prevalence, but empyema, lymphoma and other conditions can also raise it. Pleural-fluid microbiology has limited sensitivity, so tissue histology, culture and molecular testing may be needed. Empirical treatment should not replace a feasible malignancy and drug-resistance assessment.
Why is thoracic ultrasound required before pleural-fluid aspiration?
Ultrasound confirms that fluid is present, defines its depth and accessibility, shows diaphragm, lung and nearby abdominal organs, detects septation and lets the operator choose the site in the actual procedural position. This lowers wrong-site and organ-injury risk compared with a radiograph-derived landmark. It does not replace training, consent, asepsis, monitoring or a new scan after the patient moves.
When should therapeutic pleural drainage be stopped before the planned volume is reached?
Stop for chest tightness, pain, persistent cough, worsening breathlessness, hypoxaemia, syncope or haemodynamic change and reassess immediately. Drainage should be slow; the BTS procedural statement describes 1.5 litres as a usual maximum for one aspiration, not a target that overrides symptoms. Continued deterioration requires examination and imaging for pneumothorax, bleeding, re-expansion injury or another cause.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic